Attention-Deficit / Hyperactivity Disorder (ADHD)

USMLE Step 1 trap: Applies the outdated DSM-IV age-7 onset criterion instead of the DSM-5 age-12 criterion. DSM-5 requires that several inattentive or hyperactive-impulsive symptoms were present before age 12, not age 7 (which was the DSM-IV threshold).

ADHD is one of the most frequently tested pediatric psychiatry topics on USMLE Step 1, and it shows up in more nuanced ways than students expect. The exam isn't just asking you to list symptoms — it's testing whether you know the exact DSM-5 diagnostic criteria (symptom count, age of onset, setting requirements), how first-line treatment changes based on patient age, and which side effects require monitoring versus routine screening. The switch from DSM-IV to DSM-5 created a persistent misconception about age of onset that still trips up students who learned from older resources.

What makes ADHD tricky is that the exam loves to exploit the gap between what 'seems right' and what the current guidelines actually say. Two classic traps: applying the old age-7 onset criterion (now it's age 12 in DSM-5), and assuming stimulants are first-line across all age groups (they're not — behavioral therapy comes first for preschoolers aged 4–5). USMLE Step 1 will hand you a vignette with a 4-year-old and expect you to know that methylphenidate is not the first move.

The third angle is pharmacological: stimulants (amphetamines, methylphenidate) versus the non-stimulant atomoxetine (an NRI), their side effect profiles, and cardiac screening. Students often over-apply routine ECG requirements — the exam expects you to know that ECG before stimulants is only indicated with a personal or family history of cardiac disease, not for every ADHD patient. Stimulant-induced growth suppression is a high-yield gap that many students miss entirely.

From real student decks

68%have cards covering this topic

43%have mature cards

Common misconceptions

Common mistake

Wrong: ADHD symptoms must appear before age 7 per DSM-5 criteria.

Right: DSM-5 requires that several inattentive or hyperactive-impulsive symptoms were present before age 12, not age 7 (which was the DSM-IV threshold).

The age-7 onset requirement is DSM-IV, which is outdated. DSM-5 revised this threshold to age 12, meaning several inattentive or hyperactive-impulsive symptoms must have been present before age 12, not age 7. On the exam, if a vignette says symptoms were first noticed at age 10, that still satisfies the DSM-5 criterion — don't disqualify the diagnosis just because it's past age 7.

Common mistake

Wrong: Stimulant medications are first-line for ADHD in all age groups including preschool children.

Right: For preschool-aged children (4–5 years), behavioral therapy is first-line; stimulants (methylphenidate) are added only if behavior therapy fails, and atomoxetine is preferred as a non-stimulant alternative.

Stimulants are NOT first-line for everyone. For children aged 4–5 (preschool), behavioral therapy is the recommended first step; stimulants (specifically methylphenidate) are only added if behavioral therapy alone is insufficient. This distinction exists because preschoolers are more sensitive to stimulant side effects and behavioral interventions are often highly effective at this age. If the exam gives you a 4-year-old with ADHD, the answer is behavior therapy, not methylphenidate.

Common mistake

Wrong: Routine ECG is required before starting stimulant therapy in all children with ADHD.

Right: Routine ECG is not required before stimulant initiation in otherwise healthy children; it is indicated only when personal or family history suggests cardiac disease.

Routine ECG before starting stimulants sounds prudent, but current guidelines (AAP/AHA) do not require it for otherwise healthy children. The concern about stimulants and cardiac risk is real, but the evidence does not support blanket screening. ECG is indicated only when there is a personal history of cardiac disease, symptoms like palpitations or syncope, or a family history of early sudden cardiac death or arrhythmia. Ordering ECG on every ADHD patient is the wrong answer.

Common mistake

Gap: Missing that stimulants cause growth suppression requiring longitudinal monitoring

Stimulant medications can suppress appetite and slow linear growth velocity, so height and weight should be monitored regularly; drug holidays may be considered.

Stimulants suppress appetite, which over time can reduce caloric intake enough to slow linear growth velocity — this is a well-documented side effect requiring longitudinal monitoring of height and weight. Because growth suppression is dose-dependent and cumulative, clinicians may consider 'drug holidays' (e.g., summers off medication) to allow catch-up growth. If an exam vignette asks what needs to be monitored in a child on methylphenidate, growth parameters are a required part of the answer.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Know the DSM-5 diagnostic criteria precisely: 6+ symptoms of inattention and/or hyperactivity-impulsivity (5+ if ≥17 years old), present in two or more settings, causing functional impairment, with several symptoms present before age 12 — not age 7.
Know how first-line treatment differs by age: behavioral therapy alone for preschool children (4–5 years), and stimulant medications (methylphenidate or amphetamines) as first-line for school-age children and adolescents, with atomoxetine as the preferred non-stimulant alternative.
Know the expected side effects of stimulant medications (decreased appetite, insomnia, growth suppression, cardiovascular effects) and the correct cardiac screening approach — routine ECG is NOT required for healthy children, only for those with personal or family history of cardiac disease.

Can you avoid these mistakes?

A 10-year-old is brought in for evaluation. His teacher reports he has been inattentive in class since age 9, and his parents notice the same behavior at home. He meets symptom count criteria for ADHD. Does the age of symptom onset rule out an ADHD diagnosis under DSM-5? Why or why not?

A 5-year-old is diagnosed with ADHD after a thorough evaluation. The parents ask about medication. What is the most appropriate first-line treatment, and under what circumstance would you add methylphenidate?

You are about to start a 9-year-old with newly diagnosed ADHD on methylphenidate. He is otherwise healthy with no cardiac symptoms and no family history of heart disease. Does he need an ECG before starting the medication? What would change your answer?

A child has been on amphetamine salts for ADHD for 18 months. At a routine follow-up, what specific parameters should be tracked, and what intervention might be considered if growth velocity is declining?

Attention-Deficit / Hyperactivity Disorder (ADHD)

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics